Qure.ai在D系列中筹集6 500万美元的资金,用于AI保健的扩大和发展。 Qure.ai raises $65m in Series D funding for AI healthcare expansion and development.
医疗保健AI初创公司Qure.ai已经筹集了6500万美元的D轮融资,由Lightspeed和360 ONE领导,并由默克和Kae Capital参与. Qure.ai, a healthcare AI startup, has raised $65 million in Series D funding led by Lightspeed and 360 ONE, with participation from Merck and Kae Capital. 这项投资旨在加强其在美国和其他区域的存在,支持基础性AI模式的开发,并促进医疗技术的获取。 This investment aims to enhance its presence in the U.S. and other regions, support foundational AI model development, and facilitate med-tech acquisitions. 创建于2016年,Qure.ai的解决方案已在90多个国家使用,并有18个FDA批准的适用药物,专注于改善全球医疗保健的可访问性. Founded in 2016, Qure.ai's solutions are utilized in over 90 countries and have 18 FDA-cleared indications, focusing on improving global healthcare accessibility.